The medical device maker revealed in a regulatory filing submitted late Tuesday that it had identified a cybersecurity incident affecting some of its IT systems, leading to a global disruption in operations and impacting its ability to process and ship customer orders. Boston Scientific stated it has activated its incident response protocols, but the full scope of the incident and its operational and financial impacts are not yet known.